P1-067: AMBROXOL AS PHARMACOLOGICAL CHAPERONE TARGETING GBA1 AS A DISEASE MODIFYING TREATMENT FOR PARKINSON'S DISEASE DEMENTIA: A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

2006 ◽  
Vol 14 (7S_Part_5) ◽  
pp. P296-P296
Author(s):  
Stephen H. Pasternak ◽  
Carolina Silveira ◽  
Zhonghan Li ◽  
Robert Bartha ◽  
Michael Borrie ◽  
...  
2007 ◽  
Vol 22 (2) ◽  
pp. 179-186 ◽  
Author(s):  
Christopher G. Goetz ◽  
Philippe Damier ◽  
Christine Hicking ◽  
Eugene Laska ◽  
Thomas Müller ◽  
...  

2011 ◽  
Vol 27 (1) ◽  
pp. 106-112 ◽  
Author(s):  
Fabrizio Stocchi ◽  
Rupam Borgohain ◽  
Marco Onofrj ◽  
Anthony H.V. Schapira ◽  
Mohit Bhatt ◽  
...  

The Lancet ◽  
2017 ◽  
Vol 390 (10103) ◽  
pp. 1664-1675 ◽  
Author(s):  
Dilan Athauda ◽  
Kate Maclagan ◽  
Simon S Skene ◽  
Martha Bajwa-Joseph ◽  
Dawn Letchford ◽  
...  

2010 ◽  
Vol 9 (6) ◽  
pp. 573-580 ◽  
Author(s):  
Paolo Barone ◽  
Werner Poewe ◽  
Stefan Albrecht ◽  
Catherine Debieuvre ◽  
Dan Massey ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document